Pharmacotherapy of postpartum depression: An update

Expert Opinion on Pharmacotherapy

Volumn 15, Issue 9, 2014, Pages 1223-1234

  Kim, Deborah R ^a   Epperson, C Neill ^a   Weiss, Amy R ^a   Wisner, Katherine L ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Omega 3 fatty acids; Pharmacotherapy; Postpartum depression; Prevention; Treatment

Indexed keywords

CITALOPRAM; DOCOSAHEXAENOIC ACID; ESTRADIOL; ESTRIOL; ESTRONE; ICOSAPENTAENOIC ACID; MEDROXYPROGESTERONE ACETATE; PLACEBO; QUETIAPINE; SERTRALINE; ANTIDEPRESSANT AGENT; OMEGA 3 FATTY ACID; SEROTONIN UPTAKE INHIBITOR;

ALGORITHM; BECK DEPRESSION INVENTORY; BRIEF DYNAMIC PSYCHOTHERAPY; CHILDBIRTH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HORMONAL THERAPY; HUMAN; META ANALYSIS; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROMODULATION; OPEN STUDY; PEER REVIEW; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PUERPERAL DEPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; ANIMAL; BREAST FEEDING; DEPRESSION, POSTPARTUM; DIET SUPPLEMENTATION; FEMALE; TREATMENT OUTCOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; BREAST FEEDING; DEPRESSION, POSTPARTUM; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84901020833     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2014.911842     Document Type: Review

References (92)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition. VA: American Psychiatric Publishing; Arlington: 2013
2. Treatment of patients with major depressive disorder, third edition [Internet]. 2010. Available from: http://www.psychiatryonline.com/pracGuide/ pracGuideTopic-7.aspx
3. Wisner KL, Moses-Kolko EL, Sit DK. Postpartum depression: a disorder in search of a definition. Arch Womens Ment Health 2010;13(1):37-40
4. O'Hara MW, McCabe JE. Postpartum depression: current status and future directions. Annu Rev Clin Psychol 2013;9:379-407
5. di Scalea TL, Wisner KL. Pharmacotherapy of postpartum depression. Expert Opin Pharmacother 2009;10(16):2593-607
6. Wisner KL, Peindl KS, Gigliotti T, et al. Obsessions and compulsions in women with postpartum depression. J Clin Psychiatry 1999;60(3):176-80
7. Brockington IF, Macdonald E, Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium. Arch Womens Ment Health 2006;9(5):253-63
8. Abramowitz JS, Meltzer-Brody S, Leserman J, et al. Obsessional thoughts and compulsive behaviors in a sample of women with postpartum mood symptoms. Arch Womens Ment Health 2010;13(6):523-30
9. Farr SL, Dietz PM, O'Hara MW, et al. Postpartum anxiety and comorbid depression in a population-based sample of women. J Womens Health (Larchmt) 2014;Feb;23(2):120-8
10. Wisner KL, Sit DK, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry 2013;70(5):490-8
11. Do T, Hu Z, Otto J, et al. Depression and suicidality during the postpartum period after first time deliveries, active component service women and dependent spouses, U.S. armed forces, 2007-2012. MSMR 2013;20(9):2-7
12. Gavin NI, Gaynes BN, Lohr KN, et al. Perinatal depression: a systematic review of prevalence and incidence. Obstet Gynecol 2005;106(5 Pt 1):1071-83
13. Munk-Olsen T, Laursen TM, Mendelson T, et al. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 2009;66(2):189-95
14. Josefsson A, Sydsjo G. A follow-up study of postpartum depressed women: recurrent maternal depressive symptoms and child behavior after four years. Arch Womens Ment Health 2007;10(4):141-5
15. Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry 2000;157(6):924-30
16. Sacher J, Wilson AA, Houle S, et al. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry 2010;67(5):468-74
17. Glynn LM, Davis EP, Sandman CA. New insights into the role of perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides 2013;47(6):363-70
18. Sanjuan J, Martin-Santos R, Garcia-Esteve L, et al. Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry 2008;193(5):383-8
19. Binder EB, Jeffrey Newport D, Zach EB, et al. A serotonin transporter gene polymorphism predicts peripartum depressive symptoms in an at-risk psychiatric cohort. J Psychiatr Res 2010;44(10):640-6
20. Guintivano J, Arad M, Gould TD, et al. Antenatal prediction of postpartum depression with blood DNA methylation biomarkers. Mol Psychiatry 2013. [Epub ahead of print]
21. Pinsonneault JK, Sullivan D, Sadee W, et al. Association study of the estrogen receptor gene ESR1 with postpartum depression-a pilot study. Arch Womens Ment Health 2013;16(6):499-509
22. Nulman I, Koren G, Rovet J, et al. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012;169(11):1165-74
23. Mezey G, Bacchus L, Bewley S, et al. Domestic violence, lifetime trauma and psychological health of childbearing women. BJOG 2005;112(2):197-204
24. Records K, Rice MJ. Lifetime physical and sexual abuse and the risk for depression symptoms in the first 8 months after birth. J Psychosom Obstet Gynaecol 2009;30(3):181-90
25. Robertson-Blackmore E, Putnam FW, Rubinow DR, et al. Antecedent trauma exposure and risk of depression in the perinatal period. J Clin Psychiatry 2013;74(10):e942-8
26. Buttner MM, Mott SL, Pearlstein T, et al. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Womens Ment Health 2013;16(3):219-25
27. Gonidakis F, Rabavilas AD, Varsou E, et al. Maternity blues in athens, greece: a study during the first 3 days after delivery. J Affect Disord 2007;99(1-3):107-15
28. Reck C, Stehle E, Reinig K, et al. Maternity blues as a predictor of DSM-IV depression and anxiety disorders in the first three months postpartum. J Affect Disord 2009;113(1-2):77-87
29. Doucet S, Dennis CL, Letourneau N, et al. Differentiation and clinical implications of postpartum depression and postpartum psychosis. J Obstet Gynecol Neonatal Nurs 2009;38(3):269-79
30. Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry 2009;166(4):405-8
31. Pawlby S, Sharp D, Hay D, et al. Postnatal depression and child outcome at 11 years: the importance of accurate diagnosis. J Affect Disord 2008;107(1-3):241-5
32. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 2010;303(19):1961-9
33. Brand SR, Brennan PA. Impact of antenatal and postpartum maternal mental illness: how are the children? Clin Obstet Gynecol 2009;52(3):441-55
34. Easterbrooks MA, Bartlett JD, Raskin M, et al. Limiting home visiting effects: maternal depression as a moderator of child maltreatment. Pediatrics 2013;132(Suppl 2):S126-33
35. Buist A. Childhood abuse, postpartum depression and parenting difficulties: a literature review of associations. Aust NZ J Psychiatry 1998;32(3):370-8
36. Dennis CL, McQueen K. Does maternal postpartum depressive symptomatology influence infant feeding outcomes? Acta Paediatr 2007;96(4):590-4
37. Dennis CL, McQueen K. The relationship between infant-feeding outcomes and postpartum depression: a qualitative systematic review. Pediatrics 2009;123(4):e736-51
38. Cerimele JM, Vanderlip ER, Croicu CA, et al. Presenting symptoms of women with depression in an obstetrics and gynecology setting. Obstet Gynecol 2013;122(2 Pt 1):313-18
39. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. development of the 10-item edinburgh postnatal depression scale. Br J Psychiatry 1987;150:782-6
40. Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry 2000;157(11):1873-5
41. Frey BN, Simpson W, Wright L, et al. Sensitivity and specificity of the mood disorder questionnaire as a screening tool for bipolar disorder during pregnancy and the postpartum period. J Clin Psychiatry 2012;73(11):1456-61
42. Robakis TK, Williams KE. Biologically based treatment approaches to the patient with resistant perinatal depression. Arch Womens Ment Health 2013;16(5):343-51
43. Kim DR, Sockol L, Barber JP, et al. A survey of patient acceptability of repetitive transcranial magnetic stimulation (TMS) during pregnancy. J Affect Disord 2011;129(1-3):385-90
44. Munk-Olsen T, Gasse C, Laursen TM. Prevalence of antidepressant use and contacts with psychiatrists and psychologists in pregnant and postpartum women. Acta Psychiatr Scand 2012;125(4):318-24
45. Pearlstein TB, Zlotnick C, Battle CL, et al. Patient choice of treatment for postpartum depression: a pilot study. Arch Womens Ment Health 2006;9(6):303-8
46. Patel SR, Wisner KL. Decision making for depression treatment during pregnancy and the postpartum period. Depress Anxiety 2011;28(7):589-95
47. Sockol LE, Epperson CN, Barber JP. Preventing postpartum depression: a meta-analytic review. Clin Psychol Rev 2013;33(8):1205-17
48. Misri S, Abizadeh J, Albert G, et al. Restoration of functionality in postpartum depressed mothers: an open-label study with escitalopram. J Clin Psychopharmacol 2012;32(5):729-32
49. Hantsoo L, Ward-O'Brien D, Czarkowski KA, et al. A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression. Psychopharmacology (Berl) 2014;231(5):939-48
50. Sharp DJ, Chew-Graham C, Tylee A, et al. A pragmatic randomised controlled trial to compare antidepressants with a community-based psychosocial intervention for the treatment of women with postnatal depression: the RESPOND trial. Health Technol Assess 2010;14(43):iii-v.ix-xi.1-153
51. Bloch M, Meiboom H, Lorberblatt M, et al. The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2012;73(2):235-41
52. Henderson P. Comments on 'postpartum depression' article by dr wisner and colleagues. J Clin Psychopharmacol 2007;27(3):321; author reply 322-5
53. Wisner KL, Hanusa BH, Perel JM, et al. Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 2006;26(4):353-60
54. De Crescenzo F, Perelli F, Armando M, et al. Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials. J Affect Disord 2014;152:154:39-44
55. Warden D, Rush AJ, Trivedi MH, et al. The STAR*D project results: a comprehensive review of findings. Curr Psychiatry Rep 2007;9(6):449-59
56. Amin Z, Canli T, Epperson CN. Effect of estrogen-serotonin interactions on mood and cognition. Behav Cogn Neurosci Rev 2005;4(1):43-58
57. Craig MC. Should psychiatrists be prescribing oestrogen therapy to their female patients? Br J Psychiatry 2013;202(1):9-13
58. Moses-Kolko EL, Berga SL, Kalro B, et al. Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 2009;52(3):516-29
59. Perheentupa A, Ruokonen A, Tapanainen JS. Transdermal estradiol treatment suppresses serum gonadotropins during lactation without transfer into breast milk. Fertil Steril 2004;82(4):903-7
60. Schiller CE, O'Hara MW, Rubinow DR, et al. Estradiol modulates anhedonia and behavioral despair in rats and negative affect in a subgroup of women at high risk for postpartum depression. Physiol Behav 2013;119:137-44
61. Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347(9006):930-3
62. Tsai R, Schaffir J. Effect of depot medroxyprogesterone acetate on postpartum depression. Contraception 2010;82(2):174-7
63. Greenberg JA, Bell SJ, Ausdal WV. Omega-3 fatty acid supplementation during pregnancy. Rev Obstet Gynecol 2008;1(4):162-9
64. da Rocha CM, Kac G. High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression. Matern Child Nutr 2012;8(1):36-48
65. Shapiro GD, Fraser WD, Seguin JR. Emerging risk factors for postpartum depression: serotonin transporter genotype and omega-3 fatty acid status. Can J Psychiatry 2012;57(11):704-12
66. Markhus MW, Skotheim S, Graff IE, et al. Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depression. PLoS One 2013;3;8(7):e67617
67. Freeman MP. Complementary and alternative medicine for perinatal depression. J Affect Disord 2009;112(1-3):1-10
68. Wojcicki JM, Heyman MB. Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. J Matern Fetal Neonatal Med 2011;24(5):680-6
69. Deligiannidis KM, Freeman MP. Complementary and alternative medicine therapies for perinatal depression. Best Pract Res Clin Obstet Gynaecol 2014;28(1):85-95
70. Llorente AM, Jensen CL, Voigt RG, et al. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol 2003;188(5):1348-53
71. Doornbos B, van Goor SA, Dijck-Brouwer DA, et al. Supplementation of a low dose of DHA or DHA+AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(1):49-52
72. Makrides M, Gibson RA, McPhee AJ, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010;304(15):1675-83
73. Mozurkewich E, Chilimigras J, Klemens C, et al. The mothers, omega-3 and mental health study. BMC Pregnancy Childbirth 2011;11:46
74. Mozurkewich EL, Clinton CM, Chilimigras JL, et al. The mothers, omega-3, and mental health study: a double-blind, randomized controlled trial. Am J Obstet Gynecol 2013;208(4):313.e1-9
75. Freeman MP, Hibbeln JR, Wisner KL, et al. Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand 2006;113(1):31-5
76. Freeman MP, Davis M, Sinha P, et al. Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study. J Affect Disord 2008;110(1-2):142-8
77. Rees AM, Austin MP, Parker GB. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 2008;42(3):199-205
78. Mokhber N, Namjoo M, Tara F, et al. Effect of supplementation with selenium on postpartum depression: a randomized double-blind placebo-controlled trial. J Matern Fetal Neonatal Med 2011;24(1):104-8
79. Kendell RE, Wainwright S, Hailey A, et al. The influence of childbirth on psychiatric morbidity. Psychol Med 1976;6(2):297-302
80. Sit DK, Perel JM, Helsel JC, et al. Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 2008;69(4):652-8
81. Wisner KL, Perel JM, Peindl KS, et al. Prevention of postpartum depression: a pilot randomized clinical trial. Am J Psychiatry 2004;161(7):1290-2
82. Wisner KL, Parry BL, Piontek CM. Clinical practice. Postpartum depression. N Engl J Med 2002;347(3):194-9
83. Wisner KL, Perel JM, Peindl KS, et al. Prevention of recurrent postpartum depression: a randomized clinical trial. J Clin Psychiatry 2001;62(2):82-6
84. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003;361(9358):653-61
85. Kaymaz N, van Os J, Loonen AJ, et al. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008;69(9):1423-36
86. Studd JW. A guide to the treatment of depression in women by estrogens. Climacteric 2011;14(6):637-42
87. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163(1):28-40
88. Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration, Rockville, MD; 1976
89. Ip S, Chung M, Raman G, et al. A summary of the agency for healthcare research and quality's evidence report on breastfeeding in developed countries. Breastfeed Med 2009;4(Suppl 1):S17-30
90. Davanzo R, Copertino M, De Cunto A, et al. Antidepressant drugs and breastfeeding: a review of the literature. Breastfeed Med 2011;6(2):89-98
91. Berle JO, Spigset O. Antidepressant use during breastfeeding. Curr Womens Health Rev 2011;7(1):28-34
92. Lanza di Scalea T, Wisner KL. Antidepressant medication use during breastfeeding. Clin Obstet Gynecol 2009;52(3):483-97